|
The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) represents the research-based pharmaceutical companies and associations across the globe. The research-based pharmaceutical industry’s 1.3 million employees research, develop and provide medicines and vaccines that improve the life of patients worldwide. Based in Geneva, IFPMA has official relations with the United Nations and contributes industry expertise to help the global health community find solutions that improve global health. IFPMA manages global initiatives including: IFPMA Developing World Health Partnerships studies and identifies trends for the research-based pharmaceutical industry's long-term partnership programs to improve health in developing countries; IFPMA Code of Practice sets standards for ethical promotion of medicines; IFPMA Clinical Trials Portal helps patients and health professionals learn about ongoing clinical trials and trial results. ==History== IFPMA was founded in 1968.〔(【引用サイトリンク】title=About IFPMA )〕 In 2012 IFPMA released a strengthened code of ethics and professional standards. The International Pharmaceutical Congress Advisory Association (IPCAA) works in partnership with the regulatory bodies European Federation of Pharmaceutical Industries and Associations (EFPIA) and IFPMA.〔(【引用サイトリンク】title=IFPMA EFPIA IPCAA )〕 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「International Federation of Pharmaceutical Manufacturers & Associations」の詳細全文を読む スポンサード リンク
|